CA2498951C - Method for enriching procaryotic dna - Google Patents
Method for enriching procaryotic dna Download PDFInfo
- Publication number
- CA2498951C CA2498951C CA2498951A CA2498951A CA2498951C CA 2498951 C CA2498951 C CA 2498951C CA 2498951 A CA2498951 A CA 2498951A CA 2498951 A CA2498951 A CA 2498951A CA 2498951 C CA2498951 C CA 2498951C
- Authority
- CA
- Canada
- Prior art keywords
- dna
- procaryotic
- polypeptide
- protein
- procaryotic dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 60
- 229920001184 polypeptide Polymers 0.000 claims abstract description 40
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 40
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 40
- 108020004414 DNA Proteins 0.000 claims description 132
- 210000001124 body fluid Anatomy 0.000 claims description 19
- 239000010839 body fluid Substances 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 11
- 239000011859 microparticle Substances 0.000 claims description 9
- 239000011159 matrix material Substances 0.000 claims description 8
- 101000947157 Homo sapiens CXXC-type zinc finger protein 1 Proteins 0.000 claims description 6
- 238000002955 isolation Methods 0.000 claims description 6
- 102100036168 CXXC-type zinc finger protein 1 Human genes 0.000 claims description 5
- 108010060818 Toll-Like Receptor 9 Proteins 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 3
- 238000001962 electrophoresis Methods 0.000 claims description 2
- 238000000338 in vitro Methods 0.000 claims description 2
- 102100033117 Toll-like receptor 9 Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 abstract description 41
- 102000004169 proteins and genes Human genes 0.000 abstract description 33
- 230000027455 binding Effects 0.000 abstract description 12
- 238000001514 detection method Methods 0.000 description 24
- 238000003752 polymerase chain reaction Methods 0.000 description 22
- 244000052769 pathogen Species 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 16
- 239000008280 blood Substances 0.000 description 16
- 241000282414 Homo sapiens Species 0.000 description 14
- 238000000926 separation method Methods 0.000 description 13
- 230000001717 pathogenic effect Effects 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- 244000052616 bacterial pathogen Species 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 238000007857 nested PCR Methods 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 4
- 101710096438 DNA-binding protein Proteins 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 108010067770 Endopeptidase K Proteins 0.000 description 3
- 102000008235 Toll-Like Receptor 9 Human genes 0.000 description 3
- 108020005202 Viral DNA Proteins 0.000 description 3
- 102000023732 binding proteins Human genes 0.000 description 3
- 108091008324 binding proteins Proteins 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000007834 ligase chain reaction Methods 0.000 description 3
- 239000012139 lysis buffer Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000009870 specific binding Effects 0.000 description 3
- 230000004568 DNA-binding Effects 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000193996 Streptococcus pyogenes Species 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- -1 agaroses Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000009640 blood culture Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000003196 chaotropic effect Effects 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000304 virulence factor Substances 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 101710103504 CXXC-type zinc finger protein 1 Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108010058683 Immobilized Proteins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000007474 Multiprotein Complexes Human genes 0.000 description 1
- 108010085220 Multiprotein Complexes Proteins 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical group [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 101150102573 PCR1 gene Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 108010011834 Streptolysins Proteins 0.000 description 1
- 229920006328 Styrofoam Polymers 0.000 description 1
- 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 description 1
- 101150038509 TLR9 gene Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 101150037019 bopE gene Proteins 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000005294 ferromagnetic effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000001951 hemoperfusion Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000005291 magnetic effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000004912 pericardial fluid Anatomy 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008261 styrofoam Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02020904.5 | 2002-09-18 | ||
| EP02020904A EP1400589B1 (de) | 2002-09-18 | 2002-09-18 | Verfahren zum Nachweis prokaryontischer DNA |
| PCT/EP2003/008825 WO2004033683A1 (de) | 2002-09-18 | 2003-08-08 | Verfahren zur anreicherung prokaryontischer dna |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2498951A1 CA2498951A1 (en) | 2004-04-22 |
| CA2498951C true CA2498951C (en) | 2013-04-23 |
Family
ID=31896878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2498951A Expired - Fee Related CA2498951C (en) | 2002-09-18 | 2003-08-08 | Method for enriching procaryotic dna |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8062854B2 (https=) |
| EP (1) | EP1400589B1 (https=) |
| JP (1) | JP4447459B2 (https=) |
| KR (1) | KR20050057152A (https=) |
| CN (1) | CN1681925A (https=) |
| AT (1) | ATE335816T1 (https=) |
| AU (1) | AU2003260392A1 (https=) |
| CA (1) | CA2498951C (https=) |
| DE (1) | DE50207801D1 (https=) |
| DK (1) | DK1400589T3 (https=) |
| ES (1) | ES2266374T3 (https=) |
| WO (1) | WO2004033683A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1400589T3 (da) | 2002-09-18 | 2006-11-27 | Sirs Lab Gmbh | Fremgangsmåde til påvisning af prokaryotisk DNA |
| DE102005001889B4 (de) * | 2005-01-14 | 2012-03-29 | Sirs-Lab Gmbh | Verfahren zur Steigerung der Bindungskapazität und -effizienz eines Proteins, das nicht methylierte CPG-Motive enthaltende DNA spezifisch bindet |
| ES2384571T3 (es) * | 2004-03-05 | 2012-07-09 | Sirs-Lab Gmbh | Procedimiento para el enriquecimiento y/o la separación de ADN procariota mediante una proteína que se une específicamente a ADN que contiene motivos CpG no metilados |
| GB0413688D0 (en) * | 2004-06-18 | 2004-07-21 | Novartis Forschungsstiftung | Analysis of methylated nucleic acid |
| DE202005009490U1 (de) * | 2005-06-16 | 2006-10-19 | Sirs-Lab Gmbh | Vorrichtung zur Anreicherung/Abtrennung von nicht-methylierte CpG-Motive enthaltender DNA |
| DE102005034628B4 (de) * | 2005-07-19 | 2007-08-23 | Epigenomics Ag | Verfahren zur Untersuchung von Cytosin-Methylierungen in DNA |
| DE102007041864B4 (de) | 2007-09-04 | 2012-05-03 | Sirs-Lab Gmbh | Verfahren zum Nachweis von Bakterien und Pilzen |
| DK3067431T3 (da) | 2010-09-15 | 2019-10-14 | Debiopharm Int Sa | Indretning omfattende blodkomponenter til at adskille målmolekyler eller partikler fra prøver |
| US8980553B2 (en) * | 2011-04-02 | 2015-03-17 | New England Biolabs, Inc. | Methods and compositions for enriching either target polynucleotides or non-target polynucleotides from a mixture of target and non-target polynucleotides |
| US9145580B2 (en) * | 2011-04-02 | 2015-09-29 | New England Biolabs, Inc. | Methods and compositions for enriching either target polynucleotides or non-target polynucleotides from a mixture of target and non-target polynucleotides |
| DE102012219142B4 (de) | 2012-10-19 | 2016-02-25 | Analytik Jena Ag | Verfahren zum Trennen, Erfassen oder Anreichern von unterschiedlichen DNA-Spezies |
| US12612615B2 (en) | 2019-04-26 | 2026-04-28 | Thermo Fisher Scientific Baltics, UAB | Isolated nucleic acid binding domains |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| WO1997005484A1 (en) | 1995-07-28 | 1997-02-13 | Beth Israel Deaconess Medical Center, Inc. | A method of and test kit for mutagenesis testing |
| EP1248798A2 (en) | 1999-08-18 | 2002-10-16 | Fraunhofer-Gesellschaft Zur Förderung Der Angewandten Forschung E.V. | Human dna sequences |
| JP2002034565A (ja) | 2000-07-19 | 2002-02-05 | Japan Science & Technology Corp | 細菌ｄｎａを特異的に認識する受容体タンパク質 |
| DK1400589T3 (da) | 2002-09-18 | 2006-11-27 | Sirs Lab Gmbh | Fremgangsmåde til påvisning af prokaryotisk DNA |
| ES2384571T3 (es) | 2004-03-05 | 2012-07-09 | Sirs-Lab Gmbh | Procedimiento para el enriquecimiento y/o la separación de ADN procariota mediante una proteína que se une específicamente a ADN que contiene motivos CpG no metilados |
| GB0423991D0 (en) | 2004-10-29 | 2004-12-01 | Univ Edinburgh | Applications of nucleic acid fragments |
-
2002
- 2002-09-18 DK DK02020904T patent/DK1400589T3/da active
- 2002-09-18 AT AT02020904T patent/ATE335816T1/de active
- 2002-09-18 EP EP02020904A patent/EP1400589B1/de not_active Expired - Lifetime
- 2002-09-18 ES ES02020904T patent/ES2266374T3/es not_active Expired - Lifetime
- 2002-09-18 DE DE50207801T patent/DE50207801D1/de not_active Expired - Lifetime
-
2003
- 2003-08-08 WO PCT/EP2003/008825 patent/WO2004033683A1/de not_active Ceased
- 2003-08-08 AU AU2003260392A patent/AU2003260392A1/en not_active Abandoned
- 2003-08-08 CN CNA038222337A patent/CN1681925A/zh active Pending
- 2003-08-08 US US10/528,235 patent/US8062854B2/en not_active Expired - Fee Related
- 2003-08-08 JP JP2004542300A patent/JP4447459B2/ja not_active Expired - Fee Related
- 2003-08-08 CA CA2498951A patent/CA2498951C/en not_active Expired - Fee Related
- 2003-08-08 KR KR1020057003719A patent/KR20050057152A/ko not_active Ceased
-
2011
- 2011-10-05 US US13/253,661 patent/US8288115B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1400589A1 (de) | 2004-03-24 |
| JP4447459B2 (ja) | 2010-04-07 |
| US20120040363A1 (en) | 2012-02-16 |
| ATE335816T1 (de) | 2006-09-15 |
| WO2004033683A1 (de) | 2004-04-22 |
| DK1400589T3 (da) | 2006-11-27 |
| DE50207801D1 (de) | 2006-09-21 |
| JP2005538737A (ja) | 2005-12-22 |
| KR20050057152A (ko) | 2005-06-16 |
| ES2266374T3 (es) | 2007-03-01 |
| US8062854B2 (en) | 2011-11-22 |
| CN1681925A (zh) | 2005-10-12 |
| CA2498951A1 (en) | 2004-04-22 |
| EP1400589B1 (de) | 2006-08-09 |
| US8288115B2 (en) | 2012-10-16 |
| AU2003260392A1 (en) | 2004-05-04 |
| US20100316993A1 (en) | 2010-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8288115B2 (en) | Method for enriching a prokaryotic DNA | |
| CN1187362C (zh) | 核酸的固相分离法 | |
| EP2505666B1 (en) | Methods and compositions for enriching either target polynucleotides or non-target polynucleotides from a mixture of target and non-target polynucleotides | |
| US20080305528A1 (en) | Isolation of nucleic acids | |
| JP2004501054A (ja) | 核酸の単離 | |
| US20150159207A1 (en) | Use of markers including nucleotide sequence based codes to monitor methods of detection and identification of genetic material | |
| WO1999054506A1 (en) | Method of isolating target specific oligonucleotide ligands | |
| CN103695419B (zh) | 一种病毒核酸提取试剂 | |
| CN101268189A (zh) | 分离核酸的方法 | |
| CA2558515A1 (en) | Method of enriching and/or separating prokaryotic dna by means of a protein which specifically binds dna containing non-methylated cpg motifs | |
| Blackwell | [41] Selection of protein binding sites from random nucleic acid sequences | |
| CN111944874B (zh) | 一种筛选鉴定胁迫应答基因表达调控因子的方法 | |
| US11345959B2 (en) | Method for exploring useful genetic resources through bulk metagenome analysis and use thereof | |
| WO1996013608A3 (en) | Polynucleic acid sequences for use in the detection and differentiation of prokaryotic organisms | |
| Kapustin et al. | High-throughput method of one-step DNA isolation for PCR diagnostics of Mycobacterium tuberculosis | |
| CN115927244A (zh) | 一种基于微流控技术的单细胞ChIP-seq文库的构建方法 | |
| CN111363748A (zh) | 一种核酸适配体及其构建方法和其在检测中华鳖彩虹病毒中的应用 | |
| CN114561380B (zh) | 细菌核酸提取检测试剂、试剂盒及其方法和应用 | |
| CN119592714A (zh) | 细菌16s扩增试剂盒、检测方法及应用 | |
| Matsumura et al. | SuperSAGE as an analytical tool for host and viral gene expression | |
| WO2004056995A1 (en) | Process for producing an in vitro peptide expression library | |
| CN113025731A (zh) | 一种基于靶向扩增子富集策略的高通量病原菌检测试剂盒 | |
| Uhlén et al. | Affinity separation of nucleic acids on monosized magnetic beads | |
| Lew et al. | [37] Affinity selection of polymerase chain reaction products by DNA-binding proteins | |
| KR20170000804A (ko) | 대용량 메타지놈 분석을 통한 유용 유전자원 탐색 방법 및 이의 이용 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20160808 |